Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Randomized Experiments01:13

Randomized Experiments

6.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.9K
Group Design02:01

Group Design

8.9K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
8.9K
Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

217
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
217
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
What is an Experiment?01:12

What is an Experiment?

11.6K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
11.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bleeding Risk With Apixaban Versus Rivaroxaban: A Reference Trial Emulation Predicting the Results of COBRRA-VTE and COBRRA-AF Using US Health Care Claims.

Circulation. Population health and outcomes·2026
Same author

Systematic Evaluation of Data and Trial Fitness for Oncology Trial Emulation: Empirical Findings from the CARE Initiative.

Clinical pharmacology and therapeutics·2026
Same author

A Plasmode Simulation-Based Bias Analysis for Residual Confounding by Unmeasured Variables Leveraging Information-Rich Subsets.

Pharmacoepidemiology and drug safety·2026
Same author

Safety of IL-17A Inhibitors in Patients With Moderate to Severe Psoriasis in a US Claims Data-Based Cohort Study.

Journal of psoriasis and psoriatic arthritis·2026
Same author

Adaptive Multi-Wave Sampling for Efficient Chart Validation.

Clinical epidemiology·2026
Same author

Characterization and comparison of structured and unstructured electronic health record data mapped to MedDRA for post-marketing surveillance.

JAMIA open·2026

相关实验视频

Updated: Jul 3, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

517

随机试验和非随机模拟之间的设计差异和结果变化:RCT-DUPLICATE数据的元分析.

Rachel Heyard1, Leonhard Held1, Sebastian Schneeweiss2

  • 1Center for Reproducible Science, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

BMJ medicine
|February 13, 2024
PubMed
概括

设计模拟差异显著解释了随机对照试验 (RCT) 和现实证据 (RWE) 研究之间的差异. 在RWE研究中解决这些仿真差距可以提高与RCT发现的一致性.

关键词:
临床试验临床试验是指临床试验的临床试验.研究设计研究设计研究设计统计 统计 统计 统计

更多相关视频

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

6.9K

相关实验视频

Last Updated: Jul 3, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

517
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

6.9K

科学领域:

  • 卫生经济学和结果研究研究.
  • 流行病学研究设计和方法论.
  • 比较有效性研究比较有效性研究

背景情况:

  • 随机对照试验 (RCT) 是评估治疗疗效的黄金标准,但现实世界证据 (RWE) 研究提供了对常规临床实践中的治疗效果的见解.
  • 在RCT和RWE研究结果之间经常存在差异,可能是由于研究设计,患者种群和数据来源的差异.
  • 该RCT-DUPLICATE倡议旨在通过使用RWE数据模拟RCT来了解这些变化.

研究的目的:

  • 调查设计模拟与人群差异之间的关系,以及RCT与非随机RWE研究之间的结果差异.
  • 确定特定的仿真差异,这些差异有助于对RCT-RWE研究之间的效果估计的异质性.
  • 量化这些仿真差异对RCT和RWE研究结果一致性的影响.

主要方法:

  • 对来自RCT-DUPLICATE倡议的数据进行了元分析.
  • 该研究包括29对RCT-RWE研究,其中初级分析产生了危险比率.
  • 为了模拟32个RCT,使用了三个大型现实世界数据源:Optum Clinformatics Data Mart,IBM MarketScan和医疗保险数据.

主要成果:

  • 在RCT-RWE研究对之间的效果估计中,大多数异质性是由三个关键的仿真差异解释的:在医院开始治疗,随机中断基线治疗和延迟药物效应.
  • 将这三种仿真差异纳入元回归模型后,异质性从1.9大大减少到近1.
  • 这些发现表明,RWE研究如何模拟RCT设计的差异显著导致研究结果观察到的变化.

结论:

  • 在RCT和RWE研究之间的结果差异的很大一部分可以归因于设计模拟的差异.
  • 仔细考虑和调整模拟差异对于提高RWE研究与RCT研究结果的可靠性和可比性至关重要.
  • 这一分析强调了强大的仿真策略在现实世界证据研究中的重要性,以确保准确的比较有效性评估.